In silico identification of potential antigenic proteins and promiscuous CTL epitopes in Mycobacterium tuberculosis

Infection, Genetics and Evolution

Volumn 12, Issue 6, 2012, Pages 1312-1318

  Sundaramurthi, Jagadish Chandrabose ^a   Brindha, S ^a   Shobitha, S R ^a   Swathi, A ^a   Ramanandan, P ^a   Hanna, Luke Elizabeth ^a  

^a NATIONAL INSTITUTE FOR RESEARCH IN TUBERCULOSIS   (India)

Author keywords

Antigenic proteins; Bioinformatics; Dormancy; Epitopes; Mycobacterium tuberculosis; Vaccine

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL PROTEIN; EPITOPE;

ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM IDENTIFICATION; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; COMPUTER MODEL; CONTROLLED STUDY; LYMPHOCYTE ACTIVATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; TRANSCRIPTOMICS; UPREGULATION;

ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; COMPUTATIONAL BIOLOGY; COMPUTER SIMULATION; EPITOPES, T-LYMPHOCYTE; MYCOBACTERIUM TUBERCULOSIS; T-LYMPHOCYTES, CYTOTOXIC; TUBERCULOSIS VACCINES;

MYCOBACTERIUM TUBERCULOSIS;

EID: 84861921478     PISSN: 15671348     EISSN: 15677257     Source Type: Journal    
DOI: 10.1016/j.meegid.2012.03.023     Document Type: Article

References (47)

1. Altschul S.F., et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 1997, 25:3389-3402.
2. Amela I., et al. Pathogen proteins eliciting antibodies do not share epitopes with host proteins: a bioinformatics approach. PLoS ONE 2007, 2(6):e512.
3. Bacon J., et al. The influence of reduced oxygen availability on pathogenicity and gene expression in Mycobacterium tuberculosis. Tuberculosis 2004, 84:205-217.
4. Betts J.C., et al. Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling. Mol. Microbiol. 2002, 43:717-731.
5. Bui H.H., et al. Predicting population coverage of T-cell epitope-based diagnostics and vaccines. BMC Bioinformatics 2006, 7:153.
6. Chaitra M.G., et al. Modulation of immune responses in mice to recombinant antigens from PE and PPE families of proteins of Mycobacterium tuberculosis by the Ribi adjuvant. Vaccine 2007, 25:7168-7176.
7. Chaitra M.G., et al. Evaluation of T-cell responses to peptides with MHC class I-binding motifs derived from PE_PGRS 33 protein of Mycobacterium tuberculosis. J. Med. Microbiol. 2007, 56:466-474.
8. Chaitra M.G., et al. Characterization of T-cell immunogenicity of two PE/PPE proteins of Mycobacterium tuberculosis. J. Med. Microbiol. 2008, 57:1079-1086.
9. Cole S.T., et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 1998, 393:537-544.
10. De Groot A.S. Immunomics: discovering new targets for vaccines and therapeutics. Drug Discov. Today 2006, 11:203-209.
11. De Groot A.S., et al. Developing an epitope-driven tuberculosis (TB) vaccine. Vaccine 2005, 23(17-18):2121-2131.
12. Deenadayalan A., et al. Immunological and proteomic analysis of preparative isoelectric focusing separated culture filtrate antigens of Mycobacterium tuberculosis. Exp. Mol. Pathol. 2010, 88:156-162.
13. Fisher M.A., et al. Microarray analysis of the Mycobacterium tuberculosis transcriptional response to the acidic conditions found in phagosomes. J. Bacteriol. 2002, 184:4025-4032.
14. Flower D.R. Towards in silico prediction of immunogenic epitopes. Trends Immunol. 2003, 24:667-674.
15. Gupta S.K., et al. In silico CD4+ T-cell epitope prediction and HLA distribution analysis for the potential proteins of Neisseria meningitidis Serogroup B - a clue for vaccine development. Vaccine 2010, 28:7092-7097.
16. Kanduc D. The self/nonself issue: a confrontation between proteomes. Self Nonself. 2010, 1(3):255-258.
17. Kanduc D., et al. Non-redundant peptidomes from DAPs: towards " The Vaccine" . Autoimmun. Rev. 2007, 6(5):290-294.
18. Kumar M., et al. Immune response to Mycobacterium tuberculosis specific antigen ESAT-6 among south Indians. Tuberculosis 2010, 90:60-69.
19. Kumar M., et al. Cellular immune response to Mycobacterium tuberculosis-specific antigen culture filtrate protein-10 in south India. Med. Microbiol. Immunol. 2010, 199:11-25.
20. Li Y., et al. A proteome-scale identification of novel antigenic proteins in Mycobacterium tuberculosis toward diagnostic and vaccine development. J. Proteome Res. 2010, 9:4812-4822.
21. Lienhardt C., Zumla A. BCG: the story continues. Lancet 2005, 366:1414-1416.
22. Lin, H.H., et al., 2008. Evaluation of MHC class I peptide binding prediction servers: applications for vaccine research. BMC Immunol. 16, 9:8.
23. Lucchese G., et al. Proposing low-similarity peptide vaccines against Mycobacterium tuberculosis. J. Biomed. Biotechnol. Article ID 2010, 832341:8.
24. Ludin P., et al. Genome-wide identification of molecular mimicry candidates in parasites. PLoS ONE 2011, 6(3):e17546.
25. McMurry J., et al. Analyzing Mycobacterium tuberculosis proteomes for candidate vaccine epitopes. Tuberculosis 2005, 85:95-105.
26. Mustafa A.S., Shaban F.A. ProPred analysis and experimental evaluation of promiscuous T-cell epitopes of three major secreted antigens of Mycobacterium tuberculosis. Tuberculosis 2006, 86:115-124.
27. Muttucumaru D.G., et al. Gene expression profile of Mycobacterium tuberculosis in a non-replicating state. Tuberculosis (Edinb) 2004, 84:239-246.
28. Ohno H., et al. The effects of reactive nitrogen intermediates on gene expression in Mycobacterium tuberculosis. Cell. Microbiol. 2003, 5:637-648.
29. Ramakrishnan K., Flower D.R. Discriminating antigen and non-antigen using proteome dissimilarity: bacterial antigens. Bioinformation 2010, 4(10):445-447.
30. Raman K., et al. TargetTB: a target identification pipeline for Mycobacterium tuberculosis through an interactome, reactome and genome-scale structural analysis. BMC Syst. Biol. 2008, 2:109.
31. Raviglione M.C., Smith I.M. XDR tuberculosis-implications for global public health. J. Med. 2007, 356:656-659.
32. Ristori G., et al. Compositional bias and mimicry toward the nonself proteome in immunodominant T cell epitopes of self and nonself antigens. FASEB J. 2000, 14:431-438.
33. Rolland M., et al. Recognition of HIV-1 peptides by host CTL Is related to HIV-1 similarity to human proteins. PLoS ONE 2007, 9:823.
34. Salimi N., et al. Design and utilization of epitope-based databases and predictive tools. Immunogenetics 2010, 62:185-196.
35. Sampson S.L. Mycobacterial PE/PPE proteins at the host-pathogen interface. Clin. Dev. Immunol. 2010, 10:1155.
36. Schnappinger D., et al. Transcriptional Adaptation of Mycobacterium tuberculosis within macrophages: insights into the phagosomal environment. J. Exp. Med. 2003, 198:693-704.
37. Shah N.S., et al. Worldwide emergence of extensively drug-resistant tuberculosis. Emerg. Infect. Dis. 2007, 13:380-387.
38. Singh H., Raghava G.P. ProPred1: prediction of promiscuous MHC class-I binding sites. Bioinformatics 2003, 19:1009-1014.
39. Singh S.P., Mishra B.N. Identification and characterization of merozoite surface protein 1 epitope. Bioinformation 2009, 4:1-5.
40. Stenger S., Modlin R.L. T cell mediated immunity to Mycobacterium tuberculosis. Curr. Opin. Microbiol. 1999, 2:89-93.
41. Stewart G.R., et al. Dissection of the heat-shock response in Mycobacterium tuberculosis using mutants and microarrays. Microbiology 2002, 148:3129-3138.
42. Tang S.T., et al. Genome-based in silico identification of new Mycobacterium tuberculosis antigens activating polyfunctional CD8+ T cells in human tuberculosis. J. Immunol. 2011, 186:1068-1080.
43. Vani J., et al. A combined immuno-informatics and structure-based modeling approach for prediction of T cell epitopes of secretory proteins of Mycobacterium tuberculosis. Microbes Infect. 2006, 8:738-746.
44. Voskuil M.I., et al. Mycobacterium tuberculosis gene expression during adaptation to stationary phase and low-oxygen dormancy. Tuberculosis 2004, 84:218-227.
45. Wang J., et al. Analysis of predicted CD8+ T cell epitopes from proteins encoded by the specific RD regions of Mycobacterium tuberculosis for vaccine development and specific diagnosis. Mol. Biol. Rep. 2010, 37(4):1793-1799.
46. WHO, 2010. <> (accessed 18.01.12). http://whqlibdoc.who.int/publications/2010/9789241500340_eng.pdf.
47. Zvi A., et al. Whole genome identification of Mycobacterium tuberculosis vaccine candidates by comprehensive data mining and bioinformatic analyses. BMC Med. Genomics. 2008, 1:18.